Prof Gelareh Farshid from SA Pathology was the moderator.
The audience was invited to vote "yes" or "no" to the question "Breast density - Should we tell the women?" on the conference App before the debate started. Each speaker had 4 minutes to state their case, and once all speakers had presented, the audience was invited to comment on their own perspective or ask questions of the speakers. Following the discussion, the audience was again invited to vote on the same question.
The against team argued that there was no clear evidence that density inform would benefit women, but there was clear evidence that it could cause harms, such as false positives associated with supplementary screening. They argued that without a clear direction for what women can do about high breast density, providing them with this information will cause anxiety and this is also considered a harm, These points are outlined in the BreastScreen Australia and the Royal Australian and New Zealand College of Radiologists position statements published in 2016. The team in favour of density inform argued that full disclosure is an obligation of Australian medical practice, that withholding information damages patient trust, and that the Western Australia policy of density inform has not resulted in the harms and anxiety that many may have feared, and could be used as a foundation on which to build a national policy.
Why does the United States have Dense Breast "Inform" Laws? What I learned and why it matters
BreastScreen Australia conference debate "Breast density - Should we tell the women?"
InforMD - a new initiative to raise awareness about breast density
Breast density in screening, detection and incidence of breast cancer
The global breast density conversation: Meet one woman driving change in the United Kingdom
What to expect at a mammogram appointment